- Patent Title: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
-
Application No.: US16754171Application Date: 2018-10-08
-
Publication No.: US11649212B2Publication Date: 2023-05-16
- Inventor: James Aaron Balog , Emily Charlotte Cherney , Weifang Shan , David K. Williams , Liping Zhang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: BakerHostetler
- International Application: PCT/US2018/054819 2018.10.08
- International Announcement: WO2019/074822A 2019.04.18
- Date entered country: 2020-04-07
- Main IPC: C07D215/46
- IPC: C07D215/46 ; C07D215/14 ; C07D401/04 ; C07D401/06 ; C07D401/12 ; C07K16/28
Abstract:
The present invention provides compounds of formula (I), formula (II) or formula (III), wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.
Public/Granted literature
- US20210206723A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Public/Granted day:2021-07-08
Information query
